Starpharma Holdings Dividends and Buybacks
Dividend criteria checks 0/6
Starpharma Holdings does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Buyback Yield
Total Shareholder Yield | n/a |
Future Dividend Yield | n/a |
Dividend Growth | n/a |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
Does Starpharma Holdings (ASX:SPL) Have A Healthy Balance Sheet?
Dec 18We Think Some Shareholders May Hesitate To Increase Starpharma Holdings Limited's (ASX:SPL) CEO Compensation
Nov 22Here's Why Starpharma Holdings (ASX:SPL) Can Manage Its Debt Despite Losing Money
Mar 21We're Hopeful That Starpharma Holdings (ASX:SPL) Will Use Its Cash Wisely
Jan 26We Think Starpharma Holdings (ASX:SPL) Can Afford To Drive Business Growth
Jun 21Starpharma Holdings Limited (ASX:SPL): Is Breakeven Near?
May 16Here's Why We're Not At All Concerned With Starpharma Holdings' (ASX:SPL) Cash Burn Situation
Mar 02Is There An Opportunity With Starpharma Holdings Limited's (ASX:SPL) 27% Undervaluation?
Feb 10Starpharma Holdings Limited (ASX:SPL) Is Expected To Breakeven In The Near Future
Jan 20Did You Miss Starpharma Holdings' (ASX:SPL) Impressive 105% Share Price Gain?
Dec 28How Does Starpharma Holdings' (ASX:SPL) CEO Salary Compare to Peers?
Dec 07Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if SPL's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if SPL's dividend payments have been increasing.
Dividend Yield vs Market
Starpharma Holdings Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (SPL) | n/a |
Market Bottom 25% (AU) | 2.6% |
Market Top 25% (AU) | 6.2% |
Industry Average (Pharmaceuticals) | 2.5% |
Analyst forecast (SPL) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate SPL's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate SPL's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate SPL's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as SPL has not reported any payouts.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/23 07:47 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Starpharma Holdings Limited is covered by 12 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Dennis Hulme | APP Securities Pty Ltd. |
Tanushree Jain | Bell Potter |
Matthijs Smith | Canaccord Genuity |